International scientific community gathers in Valencia for the 9th ESWI Conference on Influenza, COVID-19, and RSV
Since it was established 30 years ago, the European Scientific Working Group on Influenza and other Acute Respiratory Viruses (ESWI) is hosting the 9TH ESWI Influenza Conference
International Pediatric COVID-19 Severity Over the Course of the Pandemic
This cohort study suggested that while intensive care unit admission decreased over the course of the pandemic in all age groups, ventilatory and oxygen support did not decrease over time in children aged younger than 5 years.
The SARS-CoV-2 Spike Protein Mutation Explorer: using an interactive application to improve the public understanding of SARS-CoV-2 variants of concern
The rapid evolution of SARS-CoV-2 resulted in variations in the spike that enhanced transmissibility or weakened vaccine protection.
Long Covid: clues about causes
This investigated the monocyte and inflammatory profiles of individuals who were hospitalised with COVID-19 during the acute phase and the convalescent period.
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
This study demonstrates durable yet compartmentalised nasal IgA and plasma antibody responses to SARSCoV-2 after infection and subsequent vaccination.
News
Policy & Recommendations
Call for action on Pandemic Prevention, Preparedness, and Response
Ahead of the UN High-level Meeting on Pandemic Prevention, Preparedness, and Response, taking place in September, ESWI has joined the Pandemic Action Network, alongside more than 90 partners, in signing a political declaration calling leaders for action.
Toward Comprehensive Care for Long Covid
The sequelae of SARS-CoV-2 infection can involve multiple organ systems and are often grouped together as “long Covid” or PASC (postacute sequelae of SARS-CoV-2)
|
ESWI Airborne: Burden of Disease
Burden of disease - A focus on acute respiratory viruses in older adults
Why should older adults be particularly careful of acute respiratory viruses? What are risk factors for adverse outcomes? Why is RSV typically under-diagnosed in adults compared with flu and what are some of the long-term impacts?
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Antibody levels and neutralizing activity progressively increased with each booster but subsequently waned over 3-6 months.
Prevention of long COVID: progress and challenges
Long COVID—the umbrella term that encompasses the post-acute and long-term sequelae of SARS-CoV-2 infection—can be profoundly disabling and might affect people for a lifetime.
COVID-19 evolving variants and how to stay safe
Why are we seeing a rising number of COVID-19 cases in some parts of the world? How is the SARS CoV 2 virus evolving? What do Governments and the public need to do to live with COVID-19 safely? Dr Maria Van Kerkhove explains in WHO's Science in 5.
Association of COVID-19 Infection With Incident Diabetes
SARS-CoV-2 infection may lead to acute and chronic sequelae. Emerging evidence suggests a higher risk of diabetes after infection, but population-based evidence is still sparse.